Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

Russell, Clark D; Millar, Jonathan E; Baillie, J Kenneth

Russell, Clark D; Millar, Jonathan E; Baillie, J Kenneth.

Russell CD; University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute Edinburgh, Edinburgh, UK.
Millar JE; Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.
Baillie JK; Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK. Electronic address: j.k.baillie@ed.ac.uk.

Lancet ; 395(10223): 473-475, 2020 02 15.

Article in English | MEDLINE | ID: covidwho-523

Subject(s)

Betacoronavirus; Coronavirus Infections/drug therapy; Glucocorticoids/therapeutic use; Pneumonia, Viral/drug therapy; COVID-19; Evidence-Based Medicine/methods; Glucocorticoids/adverse effects; Humans; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Glucocorticoids Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)30317-2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google